Session Outline
Novo Nordisk, one of Europe’s most valuable companies and the developers of popular diabetes and anti-obesity drugs, have realised the untapped potential of their data to improve the lives of patients and bring more value to their stakeholders. By democratizing their data, improving data quality, and focusing on data-driven business decisions, they are moving from reactive to proactive decision-making in a competitive and highly regulated market. Join Jorgen as he shares why data is a must-win battle, the data challenges Novo Nordisk faced, and real-life successes.
Key Takeaways
- The successes of the Global Data Office in promoting the importance of data, new use cases and raising awareness of tools available.
- Data management plays a key role in a regulated industry by ensuring quality and control, and using a platform to accelerate use cases into lines of business.
- Recognise that data needs AI and AI needs data. Better data = better AI-driven insights.
